Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

Nature, Published online: 12 November 2026; doi:10.1038/d41586-026-03705-9

Earlier CRISPR treatments require removal of a participant’s cells, a complex and costly approach.